Elevance Health Announces Appearance at Goldman Sachs 44th Annual Global Healthcare Conference
05 Jun 2023
INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, California on June 13th at 10:00 a.m. Pacific Daylight Time (PDT)/1:00 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting and selecting the “Investors” link. You may also access the link here. For those of you unable to listen to the live webcast, a replay will be available for 90 days following the presentation.
To listen to the live webcast, please visit Elevance Health’s website at least 15 minutes early to download and install any necessary audio software. Individuals who listen to the presentations will be presumed to have read Elevance Health’s recent filings with the SEC, including but not limited to its Annual Report on Form 10-K for the year ended December 31, 2022.
About Elevance Health, Inc.
Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health’s companies serve more than 118 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.